ADJUVANT IMMUNOTHERAPY

Clinical trials for ADJUVANT IMMUNOTHERAPY explained in plain language.

Never miss a new study

Get alerted when new ADJUVANT IMMUNOTHERAPY trials appear

Sign up with your email to follow new studies for ADJUVANT IMMUNOTHERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Blood test decides lung cancer treatment in new trial

Disease control Recruiting now

This study is for people with stage II-IIIB non-small cell lung cancer who have had surgery after initial treatment with immunotherapy and chemotherapy. It tests whether using a sensitive blood test (called MRD) to detect tiny amounts of leftover cancer can help decide who needs …

Matched conditions: ADJUVANT IMMUNOTHERAPY

Phase: PHASE2 • Sponsor: Guangdong Association of Clinical Trials • Aim: Disease control

Last updated Mar 25, 2026 14:07 UTC

ADJUVANT IMMUNOTHERAPY

Get alerted when new ADJUVANT IMMUNOTHERAPY trials appear

Blood test decides lung cancer treatment in new trial